Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Freeflow Ventures is an early-stage venture capital firm founded in 2019 and headquartered in Berkeley, California. The firm focuses on investing in deep tech solutions that address significant challenges in human and planetary health. Since its inception, Freeflow Ventures has invested in over 30 companies, primarily utilizing proprietary intellectual property, artificial intelligence, and machine learning to accelerate the market entry of innovative solutions.
The firm operates from its office located at 1314 Arch Street, Berkeley, CA, 94708. Freeflow Ventures has established a reputation for its commitment to supporting science-driven founders across various industries. Notable milestones include the successful funding of companies that leverage advanced technologies to create impactful solutions in healthcare and environmental sustainability.
Freeflow Ventures invests in early-stage companies within the sectors of human health and planetary health. Their investment strategy encompasses pre-seed, seed, Series A, and Series B funding rounds. The firm emphasizes deep tech that utilizes computer science and aims to support science-driven founders in diverse industries, including biomanufacturing, drug discovery, medical devices, diagnostics, consumer health, and therapeutics.
In the realm of planetary health, Freeflow Ventures focuses on sectors such as robotics, water, energy, carbon capture, advanced manufacturing, and advanced electronics. The firm seeks to partner with founders who are leveraging artificial intelligence and machine learning to develop innovative solutions that address pressing global challenges.
Freeflow Ventures has a diverse portfolio of over 30 companies, showcasing its commitment to deep tech innovations. Notable portfolio companies include:
These companies exemplify Freeflow Ventures' focus on addressing critical health and environmental challenges through advanced technology.
David Fleck: Founder & Managing Partner. David has extensive experience in venture capital and has led numerous successful investments in deep tech startups. He holds a degree in engineering from a prestigious university.
Kevin Barrett: Managing Partner. Kevin brings a wealth of knowledge in technology commercialization and has a strong background in supporting early-stage companies. He has previously worked at leading venture firms and has a degree in business administration.
Steve Roy: Operating Partner. Steve specializes in operational support for portfolio companies, leveraging his experience in scaling startups. He has a background in engineering and has worked with various tech companies.
Adam Wierman: Scientific Advisory Board Member. Adam is a recognized expert in artificial intelligence and its applications in healthcare. He has published extensively in the field and holds a Ph.D. in computer science.
Dave Schaffer: Scientific Advisory Board Member. Dave has a strong background in biotechnology and has been involved in several successful biotech ventures. He holds a Ph.D. in molecular biology.
To pitch Freeflow Ventures, founders should use the preferred channel available on their contact page at freeflow.io/contact/. The pitch deck should include a clear overview of the startup's mission, technology, market opportunity, and team. Founders are encouraged to provide detailed information about their product development stage and any traction achieved.
Response times may vary, but founders can expect to hear back from the firm after their submission is reviewed. Warm introductions are beneficial but not mandatory.
Freeflow Ventures has been active in the startup community, recently publishing several blog posts that highlight their investment philosophy and portfolio companies. Topics covered include insights from their scientific advisory board, advancements in AI for drug development, and reflections on Berkeley spinouts that align with their mission.
These posts indicate an ongoing commitment to sharing knowledge and engaging with their community, showcasing the firm's dedication to supporting innovative solutions in health and environmental sectors.
What are Freeflow Ventures' investment criteria?
Freeflow Ventures invests in early-stage companies that focus on deep tech solutions in human and planetary health. They look for startups in sectors such as biomanufacturing, drug discovery, medical devices, diagnostics, consumer health, and therapeutics.
How can founders apply or pitch to Freeflow Ventures?
Founders can pitch to Freeflow Ventures through their contact page at freeflow.io/contact/. They encourage submissions that clearly outline the startup's mission, technology, and market potential.
What makes Freeflow Ventures different from other venture firms?
Freeflow Ventures distinguishes itself by focusing on deep tech innovations that address critical health and environmental challenges. Their emphasis on science-driven founders and advanced technologies sets them apart in the venture capital landscape.
What is the geographic scope of Freeflow Ventures' investments?
The firm primarily invests in companies based in the United States, focusing on startups that are developing solutions relevant to both human and planetary health.
What is the typical check size for investments made by Freeflow Ventures?
While specific check sizes are not disclosed, Freeflow Ventures participates in funding rounds across pre-seed, seed, Series A, and Series B stages, indicating a flexible investment approach.
What kind of post-investment involvement does Freeflow Ventures have?
Freeflow Ventures actively engages with its portfolio companies, providing support through mentorship, strategic guidance, and access to their network of industry experts and resources.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.